High-throughput mass spectrometric cytochrome P450 inhibition screening.

We describe here a high-throughput assay to support rapid evaluation of drug discovery compounds for possible drug-drug interaction (DDI). Each compound is evaluated for its DDI potential by incubating over a range of eight concentrations and against a panel of six cytochrome P450 (CYP) enzymes: 1A2, 2C8, 2C9, 2C19, 2D6, and 3A4. The method utilizes automated liquid handling for sample preparation, and online solid-phase extraction/tandem mass spectrometry (SPE/MS/MS) for sample analyses. The system is capable of generating two 96-well assay plates in 30 min, and completes the data acquisition and analysis of both plates in about 30 min. Many laboratories that perform the CYP inhibition screening automate only part of the processes leaving a throughput bottleneck within the workflow. The protocols described in this chapter are aimed to streamline the entire process from assay to data acquisition and processing by incorporating automation and utilizing high-precision instrument to maximize throughput and minimize bottleneck.

[1]  T. Covey,et al.  Characterization and performance of MALDI on a triple quadrupole mass spectrometer for analysis and quantification of small molecules. , 2005, Analytical chemistry.

[2]  L. Cohen,et al.  Analytical approaches to determine cytochrome P450 inhibitory potential of new chemical entities in drug discovery. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  Amy Roe,et al.  The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[4]  R. Remmel,et al.  Concise review of the cytochrome P450s and their roles in toxicology. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  Christopher S. Hughes,et al.  High-throughput cytochrome P450 inhibition assays using laser diode thermal desorption-atmospheric pressure chemical ionization-tandem mass spectrometry. , 2007, Analytical chemistry.

[6]  R. Obach,et al.  Validated assays for human cytochrome P450 activities. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[7]  Li Di,et al.  Comparison of cytochrome P450 inhibition assays for drug discovery using human liver microsomes with LC-MS, rhCYP450 isozymes with fluorescence, and double cocktail with LC-MS. , 2007, International journal of pharmaceutics.

[8]  D. Kassel,et al.  Development of a High-Throughput Online Solid-Phase Extraction/Tandem Mass Spectrometry Method for Cytochrome P450 Inhibition Screening , 2010, Journal of biomolecular screening.

[9]  E. Duchoslav,et al.  A high-capacity LC/MS system for the bioanalysis of samples generated from plate-based metabolic screening. , 2001, Analytical chemistry.

[10]  R. Weaver,et al.  Cytochrome P450 inhibition using recombinant proteins and mass spectrometry/multiple reaction monitoring technology in a cassette incubation. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[11]  F Peter Guengerich,et al.  Cytochromes P450, drugs, and diseases. , 2003, Molecular interventions.

[12]  Rongda Xu,et al.  Automated high throughput ADME assays for metabolic stability and cytochrome P450 inhibition profiling of combinatorial libraries. , 2004, Journal of pharmaceutical and biomedical analysis.

[13]  Kwang-Hyeon Liu,et al.  High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry. , 2005, Rapid communications in mass spectrometry : RCM.

[14]  V. Kaushik,et al.  Mass spectrometric techniques for label-free high-throughput screening in drug discovery. , 2007, Analytical chemistry.

[15]  J. Mordenti,et al.  In vitro assessment of cytochrome P450 inhibition: strategies for increasing LC/MS-based assay throughput using a one-point IC(50) method and multiplexing high-performance liquid chromatography. , 2007, Journal of pharmaceutical sciences.